Jazz Change In Cash from 2010 to 2024

JAZZ Stock  USD 124.34  2.33  1.84%   
Jazz Pharmaceuticals Change In Cash yearly trend continues to be fairly stable with very little volatility. Change In Cash is likely to outpace its year average in 2024. During the period from 2010 to 2024, Jazz Pharmaceuticals Change In Cash regression line of annual values had r-squared of  0.1 and arithmetic mean of  140,301,427. View All Fundamentals
 
Change In Cash  
First Reported
2007-03-31
Previous Quarter
62.4 M
Current Value
922.3 M
Quarterly Volatility
253.7 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Jazz Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Jazz Pharmaceuticals' main balance sheet or income statement drivers, such as Interest Expense of 303.9 M, Other Operating Expenses of 3.4 B or Operating Income of 607.5 M, as well as many indicators such as Price To Sales Ratio of 1.93, Dividend Yield of 0.0 or PTB Ratio of 2.98. Jazz financial statements analysis is a perfect complement when working with Jazz Pharmaceuticals Valuation or Volatility modules.
  
Check out the analysis of Jazz Pharmaceuticals Correlation against competitors.

Latest Jazz Pharmaceuticals' Change In Cash Growth Pattern

Below is the plot of the Change In Cash of Jazz Pharmaceuticals PLC over the last few years. It is Jazz Pharmaceuticals' Change In Cash historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Jazz Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Change In Cash10 Years Trend
Slightly volatile
   Change In Cash   
       Timeline  

Jazz Change In Cash Regression Statistics

Arithmetic Mean140,301,427
Geometric Mean173,591,239
Coefficient Of Variation252.53
Mean Deviation274,111,732
Median249,308,000
Standard Deviation354,299,526
Sample Variance125528.2T
Range1.3B
R-Value0.31
Mean Square Error121790.7T
R-Squared0.1
Significance0.25
Slope24,936,756
Total Sum of Squares1757394.2T

Jazz Change In Cash History

2024656.1 M
2023624.8 M
2022290 M
2021-466.3 M
2020420.4 M
2019327.7 M
2018-76.4 M

About Jazz Pharmaceuticals Financial Statements

Jazz Pharmaceuticals investors use historical fundamental indicators, such as Jazz Pharmaceuticals' Change In Cash, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Jazz Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Change In Cash624.8 M656.1 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Jazz Stock Analysis

When running Jazz Pharmaceuticals' price analysis, check to measure Jazz Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jazz Pharmaceuticals is operating at the current time. Most of Jazz Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Jazz Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jazz Pharmaceuticals' price. Additionally, you may evaluate how the addition of Jazz Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.